Misplaced Pages

Angiotech Pharmaceuticals

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Angiotech Pharmaceuticals" – news · newspapers · books · scholar · JSTOR (June 2015) (Learn how and when to remove this message)
The topic of this article may not meet Misplaced Pages's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted.
Find sources: "Angiotech Pharmaceuticals" – news · newspapers · books · scholar · JSTOR (June 2015) (Learn how and when to remove this message)
(Learn how and when to remove this message)
Angiotech Pharmaceuticals Inc
Company typePublic
IndustryPharmaceutical
Founded1992 Edit this on Wikidata
HeadquartersVancouver, British Columbia, Canada
Key peopleK. Thomas Bailey
Number of employees1450
Websitewww.angiotech.com

Angiotech was a pharmaceutical company in Vancouver, British Columbia, Canada. Angiotech was founded in 1992 by William L. Hunter, Lindsay Machan, and Larry Arsenault. It sought to develop innovative technologies and medical products primarily for local diseases and complications associated with medical device implants, surgical interventions and acute injury.

In April 2010, Angiotech acquired Haemacure manufacturing to develop human biological adhesives, hemostats and therapeutic proteins.

In 2017, Angiotech was acquired by a consortium led by the U.S. healthcare investment firm Vivo Capital and China's ZQ Capital.

References

  1. "Company Profile for Angiotech Pharmaceuticals Inc (CA;ANP)". Archived from the original on 2012-02-29. Retrieved 2008-10-10.
  2. Falconer, Kirk (2016-12-19). "Angiotech Pharmaceuticals to be acquired by Vivo, ZQ-led group". PE Hub. Retrieved 2019-10-28.

External links


Stub icon

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Misplaced Pages by expanding it.

Stub icon

This article about a Canadian corporation or company is a stub. You can help Misplaced Pages by expanding it.

Categories: